Anis Askarizadeh Selected Research

Anis Askarizadeh Research Topics

7	Neoplasms (Cancer) 04/2024 - 01/2019
2	Colonic Neoplasms (Colon Cancer) 04/2024 - 08/2023
2	Cardiotoxicity 04/2023 - 01/2023
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 07/2022
2	Hypoxia (Hypoxemia) 01/2022 - 12/2019
2	Leishmaniasis 01/2020 - 08/2017
1	Carcinoma (Carcinomatosis) 04/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Cutaneous Leishmaniasis 08/2017

6	Liposomes (Liposome)IBA 04/2024 - 01/2022
4	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2023 - 01/2022
2	liposomal doxorubicin (Doxil)FDA Link 04/2024 - 01/2022
2	Peptides (Polypeptides)IBA 10/2023 - 01/2023
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 08/2023 - 01/2023
2	VaccinesIBA 01/2020 - 08/2017
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2024
1	crocinIBA 10/2023
1	Matrix Metalloproteinases (MMPs)IBA 08/2023
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2023
1	GelatinIBA 01/2023
1	Amino Acids FDA Link 07/2022
1	Cisplatin (Platino)FDA LinkGeneric 07/2022
1	monomethoxypolyethylene glycol (MPEG)IBA 01/2022
1	bis(p-chlorophenyl)acetic acid (DDA)IBA 01/2022
1	CurcuminIBA 07/2020
1	EnzymesIBA 12/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2019
1	Glutathione (Reduced Glutathione)IBA 12/2019
1	Adenosine Triphosphate (ATP)IBA 12/2019
1	LipidsIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 01/2019
1	Oxidoreductases (Dehydrogenase)IBA 01/2019

3	Therapeutics 01/2023 - 01/2022
1	Injections 07/2022